AIT Bioscience Names Terri Pascarelli as New CEO

FOR IMMEDIATE RELEASE
Contact: Bo Kowalczyk
Bo@aitbioscience.com
1-708-698-0190
 
INDIANAPOLIS, April 15, 2015 – AIT Bioscience, LLC has appointed Terri Pascarelli, BS, MBA, as Chief Executive Officer and member, Board of Directors. Pascarelli’s appointment adds extensive business and entrepreneurial leadership to the company’s executive management team.
 
AIT Bioscience is an innovative bioanalytical laboratory positioned uniquely at the interface of large molecule and small molecule analytical methods development and analysis, supported by the industry’s only fully integrated electronic laboratory environment. These capabilities and customer-first mindset allow the company to focus on what is right for the client.
 
“When it comes to supporting biopharma drug development, AIT Bioscience is capable of finding the best solution for the situation, be it using LC-MS/MS for small molecule analysis or ligand binding analysis methods for large molecule analysis, or both,” said Ms. Pascarelli. “Delivering high quality bioanalytical service that is defined from the customer’s point of view is a big reason why I joined the company.”
 
AIT Bioscience clients include US and international biopharma and animal health companies engaged in drug development of novel medical therapies.
 
Ms. Pascarelli has held leadership positions in life science companies across start-up and Fortune 500 firms for more than 25 years. Prior to joining AIT Bioscience, she was vice president of client development for YourEncore, Inc., a leading consulting firm with offices in Indianapolis, Cincinnati and Princeton, New Jersey. Her background includes executive leadership roles as president and COO of a venture-backed, Indiana-based pharmaceutical company and for a privately held Midwest medical laboratory. She has also held leadership roles in strategy, sales and marketing, managed markets, R&D and commercial operations at Boehringer Ingelheim Pharmaceuticals, Roche Pharmaceuticals and AstraZeneca.
 
Ms. Pascarelli founded the Indiana chapter of the Healthcare Businesswomen’s Association (HBA) in 2003, and has continued to serve on the global HBA Board of Directors since its creation. In 2013, Ms. Pascarelli served as President of the HBA Corporate Board of Directors. In addition, she is a member of the Dean’s Advisory Board for Butler University College of Pharmacy and Health Sciences in Indianapolis.
 
Ms. Pascarelli earned her BS in Pharmacy from Rutgers University and an MBA from Pace University Lubin Graduate School of Business, New York.
 
About AIT Bioscience, LLC
 
AIT Bioscience, LLC, headquartered in Indianapolis, Indiana, is an integrated contract research laboratory that provides continuous process monitoring and real-time quality control processes in Ligand Binding Assay (LBA) analytics for large molecule development alongside LC-MS/MS analytics for small molecules in pre-clinical and phase I – III clinical trials. The integration of these services, supported by a state-of-the-art smart electronic laboratory environment, allows AIT Bioscience to devise the best solution for its clients, across all bioanalytical methods. AIT Bioscience delivers robust analytical methods, highly skilled client consultation, efficient sample logistics and rapid sample analysis from pre-IND through investigational new drug (IND) and new drug application (NDA). For more information, visit www.aitbioscience.com.
 
###